These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25801156)

  • 1. Acyl-2-aminobenzimidazoles: a novel class of neuroprotective agents targeting mGluR5.
    He X; Lakkaraju SK; Hanscom M; Zhao Z; Wu J; Stoica B; MacKerell AD; Faden AI; Xue F
    Bioorg Med Chem; 2015 May; 23(9):2211-20. PubMed ID: 25801156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.
    Lakkaraju SK; Mbatia H; Hanscom M; Zhao Z; Wu J; Stoica B; MacKerell AD; Faden AI; Xue F
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2275-9. PubMed ID: 25937015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury.
    Loane DJ; Stoica BA; Tchantchou F; Kumar A; Barrett JP; Akintola T; Xue F; Conn PJ; Faden AI
    Neurotherapeutics; 2014 Oct; 11(4):857-69. PubMed ID: 25096154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) attenuate microglial activation.
    Xue F; Stoica BA; Hanscom M; Kabadi SV; Faden AI
    CNS Neurol Disord Drug Targets; 2014; 13(4):558-66. PubMed ID: 24168364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.
    Ahnaou A; Langlois X; Steckler T; Bartolome-Nebreda JM; Drinkenburg WH
    Psychopharmacology (Berl); 2015 Mar; 232(6):1107-22. PubMed ID: 25323624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
    O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
    Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening.
    Renner S; Noeske T; Parsons CG; Schneider P; Weil T; Schneider G
    Chembiochem; 2005 Apr; 6(4):620-5. PubMed ID: 15744765
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced Akt/GSK-3β/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice.
    Bhat SA; Henry RJ; Blanchard AC; Stoica BA; Loane DJ; Faden AI
    J Neurochem; 2021 Jan; 156(2):225-248. PubMed ID: 31926033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
    Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
    Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
    Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
    Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
    Bao WL; Williams AJ; Faden AI; Tortella FC
    Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumbens nNOS Interneurons Regulate Cocaine Relapse.
    Smith ACW; Scofield MD; Heinsbroek JA; Gipson CD; Neuhofer D; Roberts-Wolfe DJ; Spencer S; Garcia-Keller C; Stankeviciute NM; Smith RJ; Allen NP; Lorang MR; Griffin WC; Boger HA; Kalivas PW
    J Neurosci; 2017 Jan; 37(4):742-756. PubMed ID: 28123012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists.
    Milbank JB; Knauer CS; Augelli-Szafran CE; Sakkab-Tan AT; Lin KK; Yamagata K; Hoffman JK; Zhuang N; Thomas J; Galatsis P; Wendt JA; Mickelson JW; Schwarz RD; Kinsora JJ; Lotarski SM; Stakich K; Gillespie KK; Lam WW; Mutlib AE
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4415-8. PubMed ID: 17590335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway.
    Chen T; Cao L; Dong W; Luo P; Liu W; Qu Y; Fei Z
    Neurochem Res; 2012 May; 37(5):983-90. PubMed ID: 22228200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difluorocyclobutylacetylenes as positive allosteric modulators of mGluR5 with reduced bioactivation potential.
    Degnan AP; Maxwell D; Balakrishnan A; Brown JM; Easton A; Gulianello M; Hanumegowda U; Hill-Drzewi M; Miller R; Santone KS; Senapati A; Shields EE; Sivarao DV; Westphal R; Whiterock VJ; Zhuo X; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5871-5876. PubMed ID: 27856084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).
    Turlington M; Noetzel MJ; Chun A; Zhou Y; Gogliotti RD; Nguyen ED; Gregory KJ; Vinson PN; Rook JM; Gogi KK; Xiang Z; Bridges TM; Daniels JS; Jones C; Niswender CM; Meiler J; Conn PJ; Lindsley CW; Stauffer SR
    J Med Chem; 2013 Oct; 56(20):7976-96. PubMed ID: 24050755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.